In an investigator-initiated trial conducted in China with 9 G11778A LHON patients included, all participants received recombinant adeno-associated virus 2 carrying ND4 (rAAV2-ND4) by intravitreal injection to one eye (except one patient who received injection in both eyes). This evidence concerns the gene MT-ND4 and Leber hereditary optic neuropathy.